Literature DB >> 21450625

CUORE project: implementation of the 10-year risk score.

Luigi Palmieri1, Rita Rielli, Luca Demattè, Chiara Donfrancesco, Paola Ciccarelli, Patrizia De Sanctis Caiola, Francesco Dima, Cinzia Lo Noce, Ovidio Brignoli, Alfredo Cuffari, Simona Giampaoli.   

Abstract

PURPOSE: The Italian national prevention plan 2005-2008 included 10-year cardiovascular risk (10-CR) assessment of the general population aged 35-69 years using the CUORE project risk score. General practitioners (GPs) were encouraged to collect data on risk factors and 10-CR and to contribute to the Cardiovascular Risk Observatory (CRO). The aim is to demonstrate feasibility and effectiveness of 10-CR assessment as a first step to implement primary preventive actions at the individual level.
METHODS: Data were collected using CUORE.EXE software, easily and freely downloadable by GPs from the CUORE project website (www.cuore.iss.it). CRO provides a web platform to analyse and compare data on 10-CR and risk factors at regional and national levels with the aim of supporting health policy decision processes.
RESULTS: From January 2007 to May 2010, 2,858 GPs downloaded cuore.exe; 139,269 CR assessments on 117,345 persons were sent to CRO. CR mean was 3.0% in women, 8.3% in men; 30% of men and 65% of women were at lower risk (CR < 3%), 9.2% of men and 0.4% of women were at high risk (CR ≥ 20%). Among those with at least two risk assessments (n = 5,948), 8% (95% CI 7-9%) shifted to a lower risk class after 1 year. Systolic blood pressure mean levels decreased by 1.6 mmHg (95% CI 1.2-2.1 mmHg), diastolic blood pressure by 0.9 mmHg (95% CI 0.5-1.3 mmHg), total cholesterol by 5.6 mg/dl (95% CI 4.3-6.8 mg/dl), and smokers prevalence by 3.5% (95% CI 2.5-4.6%); high-density lipoprotein cholesterol increased in women by 1 mg/dl (95% CI 0.5-1.4 mg/dl).
CONCLUSIONS: Data demonstrate that 10-CR assessment can be the first step to implement preventive actions in primary care.

Entities:  

Mesh:

Year:  2011        PMID: 21450625     DOI: 10.1177/1741826710389925

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  5 in total

1.  Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.

Authors:  Arrigo F G Cicero; Federica Fogacci; Marilisa Bove; Maddalena Veronesi; Manfredi Rizzo; Marina Giovannini; Claudio Borghi
Journal:  Adv Ther       Date:  2017-07-07       Impact factor: 3.845

2.  Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study.

Authors:  Francesco Vadini; Francesca Santilli; Giuseppe Casalini; Mario dell'Isola; Ornella Iuliani; Damiano D'Ardes; Luisa Lattanzio; Marta Di Nicola; Giancarlo Di Iorio; Patrizia Accorsi
Journal:  BMC Cardiovasc Disord       Date:  2019-07-26       Impact factor: 2.298

3.  Dietary Polyphenol Intake Is Associated with Biological Aging, a Novel Predictor of Cardiovascular Disease: Cross-Sectional Findings from the Moli-Sani Study.

Authors:  Simona Esposito; Alessandro Gialluisi; Simona Costanzo; Augusto Di Castelnuovo; Emilia Ruggiero; Amalia De Curtis; Mariarosaria Persichillo; Chiara Cerletti; Maria Benedetta Donati; Giovanni de Gaetano; Licia Iacoviello; Marialaura Bonaccio
Journal:  Nutrients       Date:  2021-05-17       Impact factor: 5.717

4.  The SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil.

Authors:  Andrea M Isidori; Giovanni Corona; Antonio Aversa; Daniele Gianfrilli; Emmanuele A Jannini; Carlo Foresta; Mario Maggi; Andrea Lenzi
Journal:  Int J Endocrinol       Date:  2014-05-15       Impact factor: 3.257

5.  Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study.

Authors:  Francesco Vadini; Federica Sozio; Giordano Madeddu; Giuseppe De Socio; Paolo Maggi; Giuseppe Nunnari; Francesca Vichi; Paola Di Stefano; Elisa Tracanna; Ennio Polilli; Antonina Sciacca; Bernardetta Zizi; Vincenzo Lai; Claudio Bartolozzi; Maria Elena Flacco; Paolo Bonfanti; Francesca Santilli; Lamberto Manzoli; Giustino Parruti
Journal:  Open Forum Infect Dis       Date:  2019-07-27       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.